CNTB Connect Biopharma Holdings: Company Book Value
Connect Biopharma (CNTB) relies on the results of global trials for treating intestinal and skin inflammation, which offsets the impact of market downturns. Leading global biochemists, attracted by stock options and the scientific environment, drive the business development. The confirmed price history on the GURU.Markets platform chart stands at 0.03, while the reliability of the trials is guaranteed by the use of pharmaceutical transport for the delivery of biomaterials.
%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CNTB_-_Connect-Biopharma_-_Company-Book-Value "Connect Pharma (CNTB): Net Asset Value from 07/04/2022 to 10/27/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for Connect Pharma (CNTB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:CNTB - Connect Biopharma Holdings Limited
This indicator reflects the objective value of net assets, capturing the actual volume of company resources as opposed to volatile market expectations. By analyzing the book capitalization of Connect Biopharma (CNTB), an investor can assess the capital cushion necessary for Connect Biopharma to successfully launch its innovative anti-inflammatory and dermatitis drugs in the US and Chinese markets.
Competitor analysis for Connect Biopharma
ARGX - Total Net Assets|BioNTech SE (BNTX) - Book Capitalization|ABVX (ABIVAX) - Company Book Value|Company Book Value ADMA Biologics, Inc. ADMA|Net Asset Value Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Book Capitalization|Accounting Value of Company Kiniksa Corp (KNSA)|Book Capitalization GRFS (Grifols, S.A.)|adaptivebiotech.com - Book Capitalization|Company Book Value Celldex Therapeutics, Inc. (CLDX)|AUPH: Accounting Value of Company|BCRX (BioCryst Pharmaceuticals Inc) - Company Book Value|Vera Corp (VERA) - Company Net Assets|DNTH (Dianthus Therapeutics) - Book Capitalization|Book Capitalization pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Company Net Assets|Accounting Value of Company Tourmaline Bio Inc (TRML)|Book Capitalization PGEN|Pharming Corp - Book Valuation of Business|NKTR: Company Book Value|UPB: Company Net Assets|ZBIO (Zenas Biopharma) - Company Book Value|Company Net Assets Immunome Inc|GOSS (Gossamer Corp) - Company Net Assets|Book Capitalization KALV|Company Book Value Septerna Inc SEPN|Accounting Capitalization pieris.com (PVLA)|SVRA: Book Capitalization|Total Stockholders' Equity Rigel Pharma RIGL|ANAB: Book Capitalization|ATXS: Company Net Assets|Company Book Value ENGN|RAPT (rapt.com) - Total Stockholders' Equity|Company Book Value Aerovate Therapeutics, Inc. (JBIO)|Accounting Capitalization ACRS|Company Book Value Kyverna KYTX|Accounting Capitalization Tiziana Life Sciences, Ltd. (TLSA)|CABA: Book Capitalization|Total Stockholders' Equity ventyxbio.com VTYX|THTX: Book Capitalization|Avalo Therapeutics, Inc. (AVTX) - Company Net Assets|ELDN - Company Net Assets|Total Net Assets Agenus, Inc|CLYM - Company Net Assets|Accounting Value of Company zurabio.com|Book Capitalization aTyr Pharma (ATYR)|Company Book Value adagene.com (ADAG)|Book Capitalization IMA|Shattuck Labs Inc - Book Valuation of Business|EQ (Equillium Bio) - Company Book Value|IMUX: Total Stockholders' Equity|Company Book Value atarabio.com (ATRA)|InflaRx (IFRX) - Net Asset Value|XFOR - Book Capitalization|Accounting Value of Company Adicet|Book Capitalization CELU|Book Capitalization INMB (inmunebio.com)|Company Book Value Barinthus Biotherapeutics plc|Kezar Life Sciences Inc. - Accounting Value of Company|SABS: Company Book Value|AKTX - Company Net Assets|ENLV: Book Capitalization|Q32 Bio (QTTB) - Book Capitalization|Book Capitalization GOVX|Company Net Assets EDSA|Company Book Value iBio Corp IBIO|Accounting Capitalization carismatx.com CARM|Company Net Assets XTL Biopharmaceuticals (XTLB)|Total Net Assets Bolt Biotherapeutics Inc. BOLT|HCWB - Book Capitalization|APVO: Company Book Value|Company Book Value AIM ImmunoTech (AIM)|Aditxt, Inc. (ADTX) - Net Asset Value|GRI - Book Capitalization|Accounting Value of Company xortx.com|Book Capitalization HIND|Book Capitalization REVB (Revelation Biosciences Inc)|Company Book Value Indaptus|BiondVax Pharmaceuticals - Accounting Value of Company|CALI: Company Book Value|AFMD - Company Net Assets|ALLK: Book Capitalization|Book Capitalization HOOKIPA Pharma|IGMS - Company Net Assets|Accounting Value of Company iTeos Pharma|OCEA (Ocean Biomedical, Inc.) - Book Capitalization|Book Valuation of Business TCBP (tcbiopharm.com)|Third Harmonic Bio, Inc. - Company Book Value